Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Anim Physiol Anim Nutr (Berl) ; 106(2): 296-307, 2022 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-34160113

RESUMO

We evaluated the effect of fermented and raw rapeseed meal (FRCM and RRSM) on the growth performance, carcass traits, serum biochemical indexes, immune status and intestinal morphology of broilers. A total of 420-day-old Arbor Acre male broilers were randomly assigned to a 1 + 2 × 3 factorial arrangement with one basal diet group, two rapeseed meal (RSM) varieties (FRCM and RRSM) and three addition levels (5%, 10% and 15%) for a duration of 42 days. FRSM significantly increased the ADG and ADFI of broilers during the 22-42 days and 1-42 days (p < 0.05) growth periods compared with RRSM groups. No significant difference was observed in ADG and ADFI between broilers fed FRSM in different dietary levels and control diets (p > 0.05), but broilers fed diet with 15% RRSM showed significantly lower ADG, ADFI and spleen index (p < 0.05). Both FRSM and RRSM in different dietary levels affected the anti-oxidation function of broilers, including a significant increase in the serum contents of superoxide dismutase (SOD) and total antioxidant capacity (T-AOC) (p < 0.05), and a significant decrease of malondialdehyde (MDA) (p < 0.05). Fermentation tends to increase the villus height of duodenum (p = 0.09), and significantly increased the villus height and V/C ratio of duodenum (p < 0.05) in birds. The duodenum villus height was the highest in the 5% FRSM group and lowest in birds of 5% RRSM group. A 10% level significantly increased the duodenal V/C ratio in both FRSM and RRSM birds. The results indicated that FRSM could be used to supplemented in broilers diet to improve the production performance and maintain good health. FRSM can be added to broilers diet at 10% without adverse effect on growth performance or immune function.


Assuntos
Brassica napus , Galinhas , Ração Animal/análise , Animais , Dieta/veterinária , Suplementos Nutricionais
2.
Front Pharmacol ; 12: 621536, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33995021

RESUMO

Thymus serrulatus, an endemic plant of Ethiopia, is traditionally used to cure various diseases and as a food ingredient. In the Ethiopian folk medicine, the decoction is orally taken as a remedy to treat diabetes and high blood pressure. The purpose of the present study was to evaluate the antioxidant and antihyperglycemic effects of the aqueous extract and of the essential oil of Thymus serrulatus. The chemical composition of the aqueous extract was determined by LC-MS and the essential oil was characterized by GC-MS analysis. Radical scavenging assays, namely scavenging of 2,2-diphenyl-1-picrylhydrazyl (DPPH•), hydroxyl (•OH), and nitric oxide (•NO), were used as a first approach to screen the potential antioxidant abilities of the samples. Alpha-amylase and α-glucosidase inhibitory studies were also employed to evaluate the in vitro antihyperglycemic potential of the plant. The in vivo blood glucose lowering effect of the extracts was assessed using hypoglycemic activity and the oral glucose tolerance test in normal and in streptozotocin induced diabetic mice. When compared to the aqueous extract, the essential oil showed superior radical scavenging activity, particularly for •NO, as well as greater inhibitory potency against α-amylase and α-glucosidase (IC50 = 0.01 mg/ml and 0.11 mg/ml, respectively). Both tested samples showed a statistically significant antihyperglycemic effect. The aqueous extract at 600 mg/kg exerted maximum antihyperglycemic activity (44.14%), followed by the essential oil (30.82%). Body weight and glucose tolerance parameters were also improved by the samples both in normal and diabetic mice. The findings of this study support the hypothesis that aqueous extract and essential oil of T. serrulatus are promising therapeutic agents.

3.
Front Pharmacol ; 12: 615228, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33883992

RESUMO

The genus Thymus is traditionally used for the treatment of hyperactive airways complaints. The purpose of the current study is to investigate the potential tracheal relaxant effect and possible mechanism(s) of the essential oil of Thymus serrulatus (TS Oil) in isolated guinea pig tracheal tissues. The essential oil was obtained from the fresh erial parts of Thymus serrulatus, and its phyto-components were identified by GC-MS analysis. Guinea pig tracheal preparations were used for testing the tracheal relaxant effect of TS Oil with the determination of the mechanism(s) involved in this relaxation. GC-MS findings reveal that terpenes, fragrance constituents, saponins, and higher fatty acids are present in TS Oil. In isolated guinea pig trachea, TS Oil inhibited carbachol (CCh, 1 µM) and K+ (80 mM)-induced contractions in a pattern similar to that of dicyclomine. TS Oil, at 0.3 mg/ml, shifted parallel CCh-curves towards the right, followed by a non-parallel shift at higher concentration (1 mg/ml), thus suppressing maximum response in the same manner as produced by dicyclomine. Pretreatment of tissues with TS Oil (1 and 3 mg/ml) also produced a rightward shift of Ca++ concentration-response curves (CRCs) in the same manner as caused by verapamil. Further, TS Oil at low concentrations (0.3 and 1 mg/ml) shifted isoprenaline-induced inhibitory CRCs towards the left and increased cAMP levels in isolated tracheal homogenates similar to papaverine, a phosphodiesterase (PDE) inhibitor. In the antimicrobial assay performed by the agar well diffusion method, TS Oil was found most active against Candida albicans and Staphylococcus aureus where the zone of inhibition measured was 28 mm. Additionally, there was little difference between standard strains of gram-positive and gram-negative bacteria. However, methicillin-resistant S. aureus (MRSA) showed a small zone of inhibition as compared to standard strains (22 mm). From these results, it can be concluded that the essential oil of T. serrulatus has the potential to produce antimicrobial effects while causing tracheal relaxation mediated possibly by anticholinergic effects, Ca++ channel blockade, and PDE inhibition whereas additional mechanism(s) cannot be ruled out.

4.
J Ethnopharmacol ; 253: 112654, 2020 May 10.
Artigo em Inglês | MEDLINE | ID: mdl-32035216

RESUMO

ETHNOPHARMACOLOGICAL RELEVANCE: Capparis tomentosa Lam. root is one of the commonly used traditional medicines for the treatment of pain and inflammatory conditions by the Kunama ethnic group of Ethiopia. Yet, its ethnomedicinal claim has not been scientifically investigated. AIM OF THE STUDY: This study aims to evaluate the anti-inflammatory and anti-nociception activities of root extracts of Capparis tomentosa Lam. MATERIALS AND METHODS: The anti-inflammatory activity of the 70% ethanolic extracts and solvent fractions was determined using invitro hyaluronidase inhibition assay and in vivo carrageenan-induced paw edema in Swiss albino mice model. The anti-nociception effect was determined using the acetic acid-induced writhing model and tail immersion model in Swiss albino mice. RESULTS: The root extract of Capparis tomentosa has exhibited significant hyaluronidase inhibition activity which was comparable with the reference drug, indomethacin. Significant inhibition of carrageenan-induced paw edema was observed in all the test sample treated mice compared to the negative control with the highest activity observed from butanol fraction which was equivalent to the effect of acetylsalicylic acid. All the root extract and solvent fractions have possessed a significant and dose-dependent abdominal writhing inhibition with the highest effect observed in the aqueous fraction. Additionally, the crude extract was found better in increasing the reaction latency of the mice to the hot water stimulus than the solvent fractions which were significant after 60-120 min compared to the distilled water treated group. The root extract and solvent fractions were also found safe at a single oral dose of 2 mg/g in Swiss albino mice. CONCLUSION: The findings of the present study may partially support the folkloric use of Capparis tomentosa root for the treatment of pain and inflammation.


Assuntos
Analgésicos/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Capparis , Edema/tratamento farmacológico , Dor/tratamento farmacológico , Extratos Vegetais/uso terapêutico , Ácido Acético , Analgésicos/química , Animais , Anti-Inflamatórios/química , Carragenina , Edema/induzido quimicamente , Feminino , Hialuronoglucosaminidase/antagonistas & inibidores , Hialuronoglucosaminidase/química , Masculino , Camundongos , Dor/induzido quimicamente , Extratos Vegetais/química , Raízes de Plantas , Testes de Toxicidade Aguda
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...